A grid search was then performed, and it was found that the best performing combination of features in terms of accuracy to distinguish the plasma-derived EV samples from patients with melanoma compared to healthy controls, was a signature consisting of PRG4 and PC ae C34:3 (Fig. 4B). This evidence concerns the gene PRG4 and melanoma.